DRP3
LIVE

Serial Number

98894218

Owner

Acadia Pharmaceuticals, Inc.

Attorney

Brian J. Focarino

Filing Date

Dec 10, 2024

Add to watchlist:

No watchlists yet
View on USPTO

DRP3 Trademark

Serial Number: 98894218

DRP3 is a trademark filed by Acadia Pharmaceuticals, Inc. on December 10, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Acadia Pharmaceuticals, Inc.

12830 El Camino Real, Suite 400
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

December 10, 2024

Registration Date

Not Registered

Published for Opposition

December 9, 2025

Goods & Services

Medical consulting with respect to neurodegenerative diseases and disorders and dementia, including dementia-related psychosis and their identification and treatment; providing medical online information for health care providers and patients in the field of neurodegenerative diseases and disorders and dementia; medical informational support services, namely, providing medical information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients and healthcare professionals all related to neurodegenerative diseases and disorders and dementia

Printed publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of neurodegenerative diseases and disorders and dementia, patient support, and medical information regarding disease diagnosis, identification, management, and treatment; printed questionnaires on medical issues

Educational services, namely, providing educational programs in the nature of classes, seminars, and workshops about neurodegenerative diseases and disorders and dementia and diagnosis, identification, management, treatment, and patient support options for these conditions; multimedia educational services in the nature of recording and production services in the fields of neurodegenerative diseases and disorders and dementia, medical informational support services, and medical information regarding disease diagnosis, identification, treatment, and management distributed via various platforms across multiple forms of transmission media; providing on-line newsletters in the field of neurodegenerative diseases and disorders and dementia, medical informational support services, and medical information regarding disease diagnosis, identification, treatment, and management; online non-downloadable electronic publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of neurodegenerative diseases and disorders and dementia, patient support, and medical information regarding disease diagnosis, identification, management, and treatment

Downloadable electronic publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of neurodegenerative diseases and disorders and dementia, patient support, and medical information regarding disease diagnosis, identification, management, and treatment

Promoting awareness of patient support offerings for neurodegenerative diseases and disorders and dementia; business administrative services for medical referrals

Testing, inspection, research, and development of diagnostic tests and questionnaires for symptoms of dementia-related psychosis, including hallucinations and delusions associated with dementia-related psychosis

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 21, 2026 EXRA
SOU EXTENSION 1 GRANTED
Feb 20, 2026 EX1G
SOU EXTENSION 1 FILED
Feb 20, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 20, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 3, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 6, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 3, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 11, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 11, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 29, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 29, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 29, 2025 CNRT
ASSIGNED TO EXAMINER
May 28, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 20, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2025 NWOS
NEW APPLICATION ENTERED
Dec 10, 2024 NWAP